Health Care/Hospital

CStone Pharmaceuticals Reports Efficacy and Safety Data from the ARROW Trial of Pralsetinib in Chinese Patients with Advanced RET Fusion-positive Non-Small Cell Lung Cancer after Platinum-based Chemotherapy at IASLC WCLC 2020

SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEx: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today announced that results from a cohort of Chinese patien...

2021-01-28 10:15 4162

Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease

DUBLIN, Jan. 28, 2021 /PRNewswire/ -- Mallinckrodt plc, a global biopharmaceutical company, announced today thatJapan's Ministry of Health, Labour and Welfare (MHLW) approved the CELLEX® extracorporeal photopheresis (ECP) system for the treatment of steroid-resistant or intolerant chronic graft...

2021-01-28 09:00 4563

Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM

SHANGHAI and HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-01-28 08:00 2380

Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM

SHANGHAI and HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-01-28 08:00 4715

Deep Longevity, Kai-Fu Lee and Medical Doctors Publish "Artificial Intelligence in Longevity Medicine"

HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group";SEHK: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and ext...

2021-01-28 06:00 5308

Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies

Sub-group analysis shows three-day earlier discharge from hospital in low-risk patients hospitalized with COVID-19 KUWAIT CITY, Jan. 28, 2021 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to ...

2021-01-28 03:57 1965

Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair

HERZLIYA, Israel, Jan. 28, 2021 /PRNewswire/ -- Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring. The transseptal AMEND ...

2021-01-28 02:04 2310

Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study

SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical compa...

2021-01-27 20:00 4527

"Ping An Good Doctor" APP Officially Gets Renamed "Ping An Health" to Focus on Medical + Healthcare

HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (stock code: 1833.HK), a leading internet healthcare services platform inChina, announced that, in line with the Company's comprehensive strategic upgrade, the "Ping An Good Doctor" APP was officially renam...

2021-01-27 19:42 5041

Bill and Melinda Gates Release 2021 Annual Letter: "The Year Global Health Went Local"

SEATTLE, Jan. 27, 2021 /PRNewswire/ -- Today, Bill and Melinda Gates share their 2021 Annual Letter, "The Year Global Health Went Local." In this year's letter, Bill and Melinda reflect on the worldwide impact of COVID-19 and the global collaboration and scientific innovation fueling one of the la...

2021-01-27 16:00 1681

AXA Hong Kong and Macau stands with Employee Benefits customers in the new normal under COVID-19 by providing free new physical and mental protection

HONG KONG, Jan. 27, 2021 /PRNewswire/ -- As the COVID-19 pandemic continues, AXA Hong Kong andMacau today announced the launch of a series of free new physical and mental health protection and services for all Employee Benefits customers, supporting corporates and their employees in this critical...

2021-01-27 15:49 1973

South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis

SEOUL, South Korea, Jan. 27, 2021 /PRNewswire/ -- Lunit, a South Korean medical AI software company, announced a partnership with a leading PACS provider INFINITT Healthcare to accelerate its global expansion. Radiologists of Leuwiliang Genera...

2021-01-27 15:37 1818

Casio to Release DERMOCAMERA™, Allowing Dermatologists to Capture Close-up and Ordinary Shots of Affected Areas Using a Single Device

TOKYO, Jan. 27, 2021 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera. The new product was created based on collaborativ...

2021-01-27 12:21 1751

Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation

HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce its innovation Xuanzhu Biopharma...

2021-01-27 11:21 6275

Speedy Detection of 13 Cancer Types using a Tiny Amount of Blood: microRNA Detection Technology

SINGAPORE, Jan. 27, 2021 /PRNewswire/ -- Globally, about 1 in 6 deaths is due to cancer. With advances in treatment, early detection and treatment of cancer greatly improves survival rates of patients. Find out how Toshiba's microRNA detection technologies contribute to cancer detection at an ult...

2021-01-27 10:00 18813

Kingston x CSD Reveals APAC Top 10 heartwarming face mask designs

* Over 3,100 entries received across all APAC regions for Kingston x CSD APAC Mask Design Competition as artists induce positivity through mask designs, share compelling life stories and reflections on 2020 * Vote online now for the favourite finalist and decide who the winner will be TAIPEI, ...

2021-01-27 10:00 2407

TUV Rheinland: Better through the pandemic with systematic occupational health and safety

COLOGNE, Germany, Jan. 27, 2021 /PRNewswire/ -- With a systematic management of occupational health and safety, companies are better prepared for the challenges of the Corona pandemic. The standard for occupational health and safety management - ISO 45001 - leads to a faster and more systematic a...

2021-01-27 09:00 1960

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta

MONTREAL, Jan. 26, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry, is pleased to announce its new corporate name, CellCarta, and brand identity.

2021-01-26 21:23 2616

Connect Biopharma Strengthens Leadership Team with Key Hire

New Chief Business Officer joins company as part of organizational growth strategy SAN DIEGO and TAICANG, SUZHOU, China, Jan. 26, 2021 /PRNewswire/ -- Connect Biopharma, a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory disea...

2021-01-26 21:00 1515

Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors

SHENZHEN, China, Jan. 26, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, today launched its new VS 9 and VS 8 Vital Signs Monitors, which are now available inEurope, Australia and other selected regions. From inpatient admissio...

2021-01-26 19:29 5509
1 ... 375376377378379380381 ... 554